Rapid myocardial infarction test SC-0982-40

myoglobincardiac troponin Icreatine kinase

Rapid test for the diagnosis of myocardial infarction (MI) to qualitatively detect cardiac Myoglobin, CK-MB and Troponin I (c Tnl) in whole blood, serum or plasma. For professional in vitro diagnostic use only. The Myoglobin/CK-MB/Troponin I Combo Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid immunoassay for the qualitative detection of human cardiac Myoglobin, CK-MB and Troponin I (c Tnl) in whole blood, serum o plasma and assists in the diagnosis of myocardial infarction (MI). Myoglobin (MYO), Creatinine Kinase MB (CK-MB) and cardiac Troponin I (cTnl) are proteins released into the bloodstream following heart damage. Myoglobin is a hemoprotein normally present in heart muscle and skeletal muscle with a molecular weight of 17.8 kDa. Myoglobin (MYO), Creatinine Kinase MB (CK-MB) and cardiac Troponin I (cTnl) are proteins released into the bloodstream following heart damage. Myoglobin is a hemoprotein normally present in heart muscle and skeletal muscle with a molecular weight of 17.8 kDa. When muscle cells are damaged, myoglobin is rapidly released into the blood due to its relatively small size. Myoglobin level increases measurably above the reference standard in the 2-4 hours following the heart attack, peaking after 9-12 hours and returning to the standard value in 24-36 hours.2,3 CK-MB is a enzyme also present in heart muscle, with a molecular weight of 87.0 kDa.4 Creatinine Kinase is a dimeric molecule formed by two subunits called “M” and “B” which combine to form three different isoenzymes: CK-MM , CK-BB and CK-MB. CK-MB is the creatinine kinase isoenzyme most involved in the metabolism of cardiac muscle tissues.